David Stejskal

4.1k total citations · 1 hit paper
130 papers, 3.3k citations indexed

About

David Stejskal is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, David Stejskal has authored 130 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 31 papers in Epidemiology and 31 papers in Physiology. Recurrent topics in David Stejskal's work include Adipokines, Inflammation, and Metabolic Diseases (23 papers), Adipose Tissue and Metabolism (10 papers) and Parkinson's Disease Mechanisms and Treatments (10 papers). David Stejskal is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (23 papers), Adipose Tissue and Metabolism (10 papers) and Parkinson's Disease Mechanisms and Treatments (10 papers). David Stejskal collaborates with scholars based in Czechia, United States and United Kingdom. David Stejskal's co-authors include Michal Karpíšek, Aimin Xu, Feng Liu, Rachel L.C. Wong, Annette W.K. Tso, Xinmei Zhang, Karen S.L. Lam, Wing‐Sun Chow, Dennis C.Y. Yeung and Zhiguang Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

David Stejskal

122 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

2008 766 citations Michal Karpíšek, David Stejskal et al. profile →

Peers

Countries citing papers authored by David Stejskal

Since Specialization

Citations

This map shows the geographic impact of David Stejskal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Stejskal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Stejskal more than expected).

Fields of papers citing papers by David Stejskal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Stejskal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Stejskal. The network helps show where David Stejskal may publish in the future.

Co-authorship network of co-authors of David Stejskal

This figure shows the co-authorship network connecting the top 25 collaborators of David Stejskal. A scholar is included among the top collaborators of David Stejskal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Stejskal. David Stejskal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First Dimension Trap‐and‐Elute Combined with Second Dimension Reversed‐Phase Liquid Chromatography Separation Using a Two‐Dimensional‐Liquid Chromatography‐Tandem Mass Spectrometry System for Sensitive Quantification of Human Insulin and Six Insulin Analogs in Plasma: Improved Chromatographic Resolution and Stability Testing 2025 ·Journal of Separation Science ·(unknown), (unknown), (unknown), (unknown), (unknown), Jan Juřica, David Stejskal	1
2	Identification and evaluation of potential microRNA markers for diagnostics in neurodegenerative diseases and correlation with other biochemical markers 2025 ·PLoS ONE ·Richard Novobilský, Pavlína Kušnierová, (unknown), (unknown), David Stejskal, Michal Bar	0
3	Fast and Easy Simultaneous Determination of Riboflavin, Folic Acid, All-Trans-Retinol and α-Tocopherol in Human Serum by LC/MS/MS for Bariatric Patients 2024 ·Journal of Chromatographic Science ·(unknown), (unknown), Marek Bužga, David Stejskal	0
4	Patient Stratification for Antibiotic Prescriptions Based on the Bound-Free Phase Detection Immunoassay of C-Reactive Protein in Serum Samples 2023 ·Biosensors ·(unknown), Desirée Baumgartner, Michal Karpíšek, David Stejskal, Noémie Boillat‐Blanco, (unknown), Marcus Panning, Nils Paust, Roland Zengerle, Konstantinos Mitsakakis	1
5	Contribution of miRNAs and Other Inflammatory Biomarkers to the Differentiation of Inflammatory and Non-Inflammatory Joint Effusions 2021 ·Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca ·Pavlína Kušnierová, (unknown), (unknown), (unknown), David Stejskal	1
6	Nutritional consequences of endoluminal gastroplasty in the treatment of morbidly obese patients 2021 ·Biomedical Papers ·Zdeněk Švagera, Evžen Machytka, (unknown), (unknown), (unknown), David Stejskal, Vincent Huberty, Marek Bužga	4
7	Alpha-defensins determination in different types of synovial fluid and parallel collected serum samples by ELISA 2021 ·Biomedical Papers ·Pavlína Kušnierová, (unknown), (unknown), (unknown), (unknown), David Stejskal	1
8	Acute Kidney Injury in Septic Patients Treated by Selected Nephrotoxic Antibiotic Agents—Pathophysiology and Biomarkers—A Review 2020 ·International Journal of Molecular Sciences ·Naděžda Petejová, Arnošt Martínek, Josef Zadražil, Marcela Káňová, (unknown), (unknown), Ivana Kacířová, (unknown), Zdeněk Švagera, David Stejskal	58
9	Serum concentrations of TFF3, S100-A11 and AIF-1 in association with systemic inflammatory response, disease stage and nodal involvement in endometrial cancer 2018 ·Pteridines ·Radovan Pilka, (unknown), David Stejskal, (unknown), (unknown), (unknown), Tomáš Adam, (unknown), (unknown), (unknown), (unknown), Dagmar Solichová, Lenka Kujovská Krčmová, Lenka Javorská, Bohuslav Melichar	0
10	Tau Protein, beta-Amyloid 1-42 and Clusterin CSF Levels in Differential Diagnosis of Parkinsonian Syndrome with Dementia (P04.156) 2013 ·Neurology ·Hana Přikrylová Vranová, Eva Hényková, Michaela Kaiserová, Kateřina Menšíková, (unknown), Jan Mareš, Petr Hluštı́k, Jana Zapletalová, Miroslav Strnad, David Stejskal, Petr Kaňovský	1
11	Metabolická problematika v léčbě urolitiázy 2009 ·Urologie pro praxi ·David Stejskal, (unknown)	0
12	THE EFFECT OF FOOT TYPE AND LATERALITY ON ANKLE SPRAIN IN ELITE FEMALE VOLLEYBALL ATHLETES 2009 ·University of Zagreb University Computing Centre (SRCE) ·(unknown), (unknown), Michal Lehnert, Pavel Kolář, David Stejskal	2
13	CARDIOTROPHIN-1 REVIEW 2008 ·Biomedical Papers ·David Stejskal, Viktor Růžička	20
14	Use of glycogen phosphorylase BB measurement with POCT in the diagnosis of acute coronary syndromes. A comparison with the ELISA method 2007 ·Biomedical Papers ·David Stejskal, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michal Karpíšek, Luděk Šprongl	10
15	Adipocyte Fatty Acid–Binding Protein Is a Plasma Biomarker Closely Associated with Obesity and Metabolic Syndrome 2006 ·Clinical Chemistry ·Aimin Xu, Yu Wang, Jian Xu, David Stejskal, Sidney Tam, Jialiang Zhang, Nelson M.S. Wat, Wai Keung Wong, Karen SL Lam	487
16	EVALUATION OF URINE N1,N12-DIACETYLSPERMINE AS POTENTIAL TUMOR MARKER FOR URINARY BLADDER CANCER 2006 ·Biomedical Papers ·David Stejskal, (unknown), (unknown), (unknown), (unknown), (unknown), Michal Karpíšek	6
17	Adiponectin concentrations as a criterion of metabolic control in persons with type 2 diabetes mellitus? 2003 ·Biomedical Papers ·David Stejskal, Viktor Růžička, (unknown), (unknown), (unknown), (unknown), Josef Bartek	7
18	OSTEOPROTEGERIN, RANK, RANKL 2001 ·Biomedical Papers ·David Stejskal, Josef Bartek, (unknown), Viktor Růžička, (unknown), (unknown)	24
19	SERUM LEPTIN AND LEPTIN RECEPTORS IN HEALTHY PREPUBERTAL CHILDREN: RELATIONS TO INSULIN RESISTANCE AND LIPID PARAMETERS, BODY MASS INDEX (BMI), TUMOR NECROSIS FACTOR α (TNFα), HEART FATTY ACID BINDING PROTEIN (hFABP), AND IgG ANTICARDIOLIPIN (ACL-IgG) 2000 ·Biomedical Papers ·Jana Malinčíková, David Stejskal, Jiří Hřebíček	6
20	RELATION BETWEEN HUMAN PLASMA CONCENTRATION OF LEPTIN AND ADIPOSIS 1999 ·(unknown), Pavel Stejskal, David Stejskal, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact